SHIMIZU Yuko
   Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine
   Position   Professor
Article types Original article
Language English
Peer review Peer reviewed
Title Validation of the brief international cognitive assessment for multiple sclerosis in Japan
Journal Formal name:Multiple sclerosis journal - experimental, translational and clinical.
ISSN code:20552173
Domestic / ForeginForegin
Volume, Issue, Page 3(4),pp.2055217317748972
Author and coauthor NIINO Masaaki, FUKAZAWA Toshiyuki, OKUNO Tatsusada, MORI Masahiro, SANJO Nobuo, OHASHI Takashi, FUKAURA Hiroaki, FUJIMORI Juichi, SHIMIZU Yuko, MIFUNE Nobuhiro, MIYAZAKi Yuusei, TAKAHASHI Eri, KIKUCHI Seiji, LANGDON Dawn, BENDICT HB Ralph, MATSUI Makoto
Publication date 2017/12
Summary Background:The Brief International Cognitive Assessment for MS (BICAMS) is a practical battery for measuring cognitive function in multiple sclerosis (MS).Objectives:We aimed to validate a Japanese version of the BICAMS in patients with MS and healthy controls.Methods:The Symbol Digit Modalities Test (SDMT), the California Verbal Learning Test-Second Edition (CVLT2) and the Brief Visuospatial Memory Test Revised (BVMTR) were administered to 156 patients with MS and 126 healthy controls (HCs). The BICAMS was re-administered in a subset of 27 MS patients and 30 HCs.Results:The mean (±SD) raw scores in the MS and HC groups were as follows: SDMT: MS 47.9 ± 14.0, HC 61.0 ± 9.5; CVLT2: MS 48.6 ± 12.6, HC 55.7 ± 10.5; BVMTR: MS 23.5 ± 8.4, HC 28.3 ± 5.4, respectively, and significant differences were found between the two groups on all tests (p < 0.0001). Cohen's d values were 1.07, 0.60, and 0.67 in SDMT, CVLT2, and BVMTR, respectively. The test-retest reliability coefficients for each test were as follows: SDMT: r = 0.93; CVLT2: r = 0.82; and BVMTR: r = 0.77 (p < 0.0001).Conclusions:This study provides results that support the reliability and validity of the BICAMS in Japan.
DOI 10.1177/20552173177489723
PMID 29339837